Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Hillevax Inc (HLVX)

Hillevax Inc (HLVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 89,995
  • Shares Outstanding, K 49,721
  • Annual Sales, $ 0 K
  • Annual Income, $ -123,570 K
  • 60-Month Beta 0.81
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.44
Trade HLVX with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.42
  • Number of Estimates 4
  • High Estimate -0.34
  • Low Estimate -0.53
  • Prior Year -0.81
  • Growth Rate Est. (year over year) +48.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6800 +7.74%
on 09/11/24
2.0700 -12.56%
on 08/22/24
+0.0200 (+1.12%)
since 08/16/24
3-Month
1.5500 +16.77%
on 07/08/24
15.2500 -88.13%
on 07/02/24
-10.9900 (-85.86%)
since 06/18/24
52-Week
1.5500 +16.77%
on 07/08/24
20.2200 -91.05%
on 03/04/24
-12.8700 (-87.67%)
since 09/18/23

Most Recent Stories

More News
3 IPO Stocks That You Want to Own

This down market is giving us some really intriguing stocks at cheap prices.

AMLX : 2.88 (-1.37%)
HLVX : 1.8100 (unch)
DCGO : 3.53 (-1.12%)
TAK : 14.82 (-0.20%)
HilleVax Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress

BOSTON, Aug. 10, 2022 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and...

HLVX : 1.8100 (unch)
HilleVax Announces Results from 5-Year Clinical Study Supporting Long-Term Immunogenicity of HIL-214 Norovirus Vaccine Candidate

Pan-Ig and HBGA blocking antibody responses persisted to year 5 No adverse events deemed related to HIL-214 BOSTON, July 20, 2022 (GLOBE NEWSWIRE)...

HLVX : 1.8100 (unch)
HilleVax Reports First Quarter 2022 Financial Results and Highlights Recent Company Progress

Initiated Phase 2b Clinical Trial of HIL-214 Vaccine Candidate for the Prevention of Norovirus-Related Acute Gastroenteritis in Infants (NOR-212) ...

HLVX : 1.8100 (unch)
HilleVax Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

BOSTON, May 03, 2022 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and...

HLVX : 1.8100 (unch)
Stock Market This Week: Five Themes To Watch

Following a volatile series of sessions, investors are entering the month of May with several reasons to be cautious.

HLVX : 1.8100 (unch)
MPC : 164.67 (+0.49%)
VWAGY : 10.9300 (+0.55%)
CNK : 28.62 (+0.10%)

Business Summary

HilleVax Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines. Its initial program, HIL-214, is a virus-like particle based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection....

See More

Key Turning Points

3rd Resistance Point 1.9467
2nd Resistance Point 1.9133
1st Resistance Point 1.8617
Last Price 1.8100
1st Support Level 1.7767
2nd Support Level 1.7433
3rd Support Level 1.6917

See More

52-Week High 20.2200
Fibonacci 61.8% 13.0881
Fibonacci 50% 10.8850
Fibonacci 38.2% 8.6819
Last Price 1.8100
52-Week Low 1.5500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar